Shandong Boan Biotechnology Co (HKSE:06955) Debt-to-Revenue : 0.57 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Shandong Boan Biotechnology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$187.5 Mil. Shandong Boan Biotechnology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$256.5 Mil. Shandong Boan Biotechnology Co's annualized Revenue for the quarter that ended in Dec. 2023 was HK$780.7 Mil. Shandong Boan Biotechnology Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.57.

Shandong Boan Biotechnology Co Debt-to-Revenue Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Debt-to-Revenue Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

N/A

1.67

0.59

0.66

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial			0.90	0.60	0.51	0.58	0.57

Competitive Comparison of Shandong Boan Biotechnology Co's Debt-to-Revenue

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Boan Biotechnology Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Debt-to-Revenue falls into.

Shandong Boan Biotechnology Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Shandong Boan Biotechnology Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(187.48	+	256.49)	/	676.096
	=	0.66

Shandong Boan Biotechnology Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(187.48	+	256.49)	/	780.732
	=	0.57

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

Shandong Boan Biotechnology Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines